Alterity Therapeutics Limited
PRNAF
$0.0101
$0.0065180.56%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.34M | -2.40M | -4.16M | -4.15M | -2.12M |
| Total Depreciation and Amortization | 23.70K | 24.30K | 24.30K | 24.20K | 24.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 244.60K | 251.50K | 100.30K | 100.10K | 103.10K |
| Change in Net Operating Assets | -654.70K | -673.20K | 1.36M | 1.36M | 528.50K |
| Cash from Operations | -2.72M | -2.80M | -2.67M | -2.67M | -1.46M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -1.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | -1.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34.10K | -34.10K | 22.20K | 22.20K | -27.40K |
| Issuance of Common Stock | 199.30K | 199.30K | 4.39M | 4.39M | 684.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.00K | -16.00K | -327.30K | -327.30K | -131.70K |
| Cash from Financing | 97.20K | 99.90K | 2.69M | 2.69M | 342.30K |
| Foreign Exchange rate Adjustments | -13.40K | -13.70K | 86.80K | 86.60K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.64M | -2.71M | 104.90K | 104.70K | -1.13M |
